PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSO100201000026C — ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS

ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS is a federal NONE award for Department of Health and Human Services (HHS) held by ELUSYS THERAPEUTICS, INC.. Estimated value $138.3M ($-499K obligated). Current period of performance ends Sep 30, 2018. Last award drew 2 bidders. Place of performance: PINE BROOK, NJ.

$138.3M
Estimated Value
$-499K
Obligated
Sep 30, 2018
PoP End / Expires
2
Bidders (last award)
More in SCOUT — score this to your firm →See related expiring contracts →

Analysis

Public

ELUSYS THERAPEUTICS, INC. holds $113.9M across 5 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Set-aside status: NONE. PoP ended Sep 30, 2018 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Contract facts

NONE
Contract numberHHSO100201000026C
AgencyDepartment of Health and Human Services (HHS)
IncumbentELUSYS THERAPEUTICS, INC.
UEIELP1DCK8L191
NAICS541711

No full NAICS 541711 intel page yet. Browse NAICS intelligence

PSCAN13
Place of performancePINE BROOK, NJ
PoP end (current)Sep 30, 2018
Obligated$-499K

ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS

Recompete timing

Public
Past PoP end (2871 days ago)

Current PoP ended Sep 30, 2018 (2871 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Track recompete timing in SCOUT →

Incumbent footprint

Public record

ELUSYS THERAPEUTICS, INC.$113.9M obligated across 5 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$113.9M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm — $90 Pilot →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. 90 days · $90 · no annual contract · cancel anytime

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open ELUSYS THERAPEUTICS, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract HHSO100201000026C?

HHSO100201000026C (ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS) is a Department of Health and Human Services (HHS) award with an estimated value of $138.3M, currently held by ELUSYS THERAPEUTICS, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on HHSO100201000026C?

ELUSYS THERAPEUTICS, INC. is the incumbent with $113.9M across 5 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2018.

When does HHSO100201000026C come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2018. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSO100201000026C